Corrigendum to“Effects of compatibility of deproteinized antler cancellous bone with various bioactive factors on their osteogenic potential” [Biomaterials 34 (2013) 9103-9114] (S0142961213009721) (10.1016/j.biomaterials.2013.08.024));Effects of compatibility of deproteinized antler cancellous bone with various bioactive factors on their osteogenic potential

Biomaterials

Volumn 34, Issue 36, 2013, Pages 9103-9114

  Zhang, Xuehui ^a,b   Xu, Mingming ^a   Song, Lin ^c   Wei, Yan ^a   Lin, Yuanhua ^b   Liu, Wentao ^d   Heng, Boon C ^e   Peng, Hui ^a   Wang, Ying ^a   Deng, Xuliang ^a,f  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

^e ETH ZURICH   (Switzerland)

^f NATIONAL ENGINEERING LABORATORY FOR DIGITAL AND MATERIAL TECHNOLOGY OF STOMATOLOGY   (China)

Author keywords

Antler; Compatibility; Icariin; Osteogenic potential; RhBMP 2; VAP

Indexed keywords

ALKALINITY; BIOACTIVITY; BONE; CALCIUM PHOSPHATE; CELL CULTURE; CHEMICAL STABILITY; DEFECTS; FLAVONOIDS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GENE EXPRESSION; PHOSPHATASES; RECOMBINANT PROTEINS; REPAIR; SCANNING ELECTRON MICROSCOPY; STEM CELLS;

ANTLER; COMPATIBILITY; ICARIIN; OSTEOGENIC POTENTIAL; RHBMP-2;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; ICARIIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; POLYPEPTIDE; REAGENT; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCAFFOLD PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VELVET ANTLER POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE MARROW CELL; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; DEER; DRUG RELEASE; DRUG STABILITY; ENZYME ACTIVITY; GENE EXPRESSION; HORN; IMPLANTATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; MANDIBLE; MANDIBLE FRACTURE; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; RABBIT; SCANNING ELECTRON MICROSCOPY; TRABECULAR BONE;

ORYCTOLAGUS CUNICULUS; RATTUS;

ANTLER; COMPATIBILITY; ICARIIN; OSTEOGENIC POTENTIAL; RHBMP-2; VAP;

ALKALINE PHOSPHATASE; ANIMALS; ANTLERS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; DEER; FLAVONOIDS; HUMANS; MALE; MANDIBLE; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PEPTIDES; PROTEINS; RABBITS; RATS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; X-RAY MICROTOMOGRAPHY;

EID: 84883795936     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2018.04.018     Document Type: Erratum

References (62)

1. Parikh S.N. Bone graft substitutes in modern orthopedics. Orthopedics 2002, 25:1301-1309.
2. Perka C., Schultz O., Spitzer R.S., Lindenhayn K., Burmester G.R., Sittinger M. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 2000, 21:1145-1153.
3. Mehta M., Schmidt-Bleek K., Duda G.N., Mooney D.J. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev 2012, 64:1257-1276.
4. Benders K.E., Weeren P.R., Badylak S.F., Saris D.B., Dhert W.J., Malda J. Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol 2013, 31:169-176.
5. Byers B.A., Guldberg R.E., Garcia A.J. Synergy between genetic and tissue engineering: Runx2 overexpression and invitro construct development enhance invivo mineralization. Tissue Eng 2004, 10:1757-1766.
6. Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., Ikada Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. JControl Release 2000, 64:133-142.
7. Zhao J., Ohba S., Komiyama Y., Shinkai M., Chung U.I., Nagamune T. Icariin: a potential osteoinductive compound for bone tissue engineering. Tissue Eng Part A 2010, 16:233-243.
8. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034.
9. Luginbuehl V., Meinel L., Merkle H.P., Gander B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004, 58:197-208.
10. Matsumoto T., Okazaki M., Inoue M., Yamaguchi S., Kusunose T., Toyonaga T., et al. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 2004, 25:3807-3812.
11. Hu J., Hou Y., Park H., Lee M. Beta-tricalcium phosphate particles as a controlled release carrier of osteogenic proteins for bone tissue engineering. JBiomed Mater Res A 2012, 100:1680-1686.
12. Liu T., Wu G., Wismeijer D., Gu Z., Liu Y. Deproteinized bovine bone functionalized with the slow delivery of BMP-2 for the repair of critical-sized bone defects in sheep. Bone 2013, 56:110-118.
13. King W.J., Krebsbach P.H. Growth factor delivery: how surface interactions modulate release invitro and invivo. Adv Drug Deliv Rev 2012, 64:1239-1256.
14. Varkey M., Gittens S.A., Uludag H. Growth factor delivery for bone tissue repair: an update. Expert Opin Drug Deliv 2004, 1:19-36.
15. Shen W., Chen X., Chen J., Yin Z., Heng B.C., Chen W., et al. The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration. Biomaterials 2010, 31:7239-7249.
16. Street J., Bao M., deGuzman L., Bunting S., Peale F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
17. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
18. Kang Y., Kim S., Khademhosseini A., Yang Y. Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials 2011, 32:6119-6130.
19. Guan S.W., Duan L.X., Li Y.Y., Wang B.X., Zhou Q.L. Anovel polypeptide from Cervus nippon Temminck proliferation of epidermal cells and NIH3T3 cell line. Acta Biochim Pol 2006, 53:395-397.
20. Laky ZQ M., Ho E., Ulm C., Matejka M., Rausch-Fan X. The effect of deer antler growth factor on the viability and proliferation of primary human alveolar osteoblast cells invitro. JStomatol Occlusion Med 2009, 2:175-178.
21. Zhou Q.L., Guo Y.J., Wang L.J., Wang Y., Liu Y.Q., Wang B.X. Velvet antler polypeptides promoted proliferation of chondrocytes and osteoblast precursors and fracture healing. Acta Pharmacol Sin 1999, 20:279-282.
22. Ma H.P., Ming L.G., Ge B.F., Zhai Y.K., Song P., Xian C.J., et al. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization invitro. JCell Biochem 2011, 112:916-923.
23. Chen K.M., Ge B.F., Ma H.P., Liu X.Y., Bai M.H., Wang Y. Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie 2005, 60:939-942.
24. Zheng D., Peng S., Yang S.H., Shao Z.W., Yang C., Feng Y., et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. Bone 2012, 51:85-92.
25. Chen K.M., Ge B.F., Liu X.Y., Ma P.H., Lu M.B., Bai M.H., et al. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie 2007, 62:388-391.
26. Hsieh T.P., Sheu S.Y., Sun J.S., Chen M.H. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis. Phytomedicine 2011, 18:176-185.
27. Zhang X., Guo Y., Li D.X., Wang R., Fan H.S., Xiao Y.M., et al. The effect of loading icariin on biocompatibility and bioactivity of porous beta-TCP ceramic. JMater Sci Mater Med 2011, 22:371-379.
28. Wang X.L., Xie X.H., Zhang G., Chen S.H., Yao D., He K., et al. Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair. JOrthop Res 2013, 31:164-172.
29. Dorozhkin S.V. Bioceramics of calcium orthophosphates. Biomaterials 2010, 31:1465-1485.
30. El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Rev Med Devices 2005, 2:87-101.
31. Tay B.K., Patel V.V., Bradford D.S. Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am 1999, 30:615-623.
32. Zhang X., Cai Q., Liu H., Heng B.C., Peng H., Song Y., et al. Osteoconductive effectiveness of bone graft derived from antler cancellous bone: an experimental study in the rabbit mandible defect model. Int J Oral Maxillofac Surg 2012, 41:1330-1337.
33. Fan J.J., Cao L.G., Wu T., Wang D.X., Jin D., Jiang S., et al. The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells. Molecules 2011, 16:10123-10133.
34. Bhakta G., Rai B., Lim Z.X., Hui J.H., Stein G.S., van Wijnen A.J., et al. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 2012, 33:6113-6122.
35. Chen S.H., Wang X.L., Xie X.H., Zheng L.Z., Yao D., Wang D.P., et al. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an invitro efficacy study. Acta Biomater 2012, 8:3128-3137.
36. Zhao L., Liu L., Wu Z., Zhang Y., Chu P.K. Effects of micropitted/nanotubular titania topographies on bone mesenchymal stem cell osteogenic differentiation. Biomaterials 2012, 33:2629-2641.
37. Wang L., Fan H., Zhang Z.Y., Lou A.J., Pei G.X., Jiang S., et al. Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized beta-tricalcium phosphate scaffold and mesenchymal stem cells. Biomaterials 2010, 31:9452-9461.
38. Luo T., Wu C., Zhang Y. The invivo osteogenesis of Mg or Zr-modified silicate-based bioceramic spheres. JBiomed Mater Res A 2012, 100:2269-2277.
39. Tuominen V.J., Ruotoistenmaki S., Viitanen A., Jumppanen M., Isola J. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 2010, 12:R56.
40. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
41. Subramani K., Ahmed W. Emerging nanotechnologies in dentistry: processes, materials and applications 2011, William Andrew.
42. Amirfeyz R., Stanley D. Allograft-prosthesis composite reconstruction for the management of failed elbow replacement with massive structural bone loss: a medium-term follow-up. JBone Jt Surg Br 2011, 93:1382-1388.
43. Mellor D.J., Littin K.E. Using science to support ethical decisions promoting humane livestock slaughter and vertebrate pest control. Anim Welfare 2004, 13:127-132.
44. Yang Y.G., Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007, 7:519-531.
45. Bose S., Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater 2012, 8:1401-1421.
46. Ginebra M.P., Canal C., Espanol M., Pastorino D., Montufar E.B. Calcium phosphate cements as drug delivery materials. Adv Drug Deliv Rev 2012, 64:1090-1110.
47. Lee W.H., Zavgorodniy A.V., Loo C.Y., Rohanizadeh R. Synthesis and characterization of hydroxyapatite with different crystallinity: effects on protein adsorption and release. JBiomed Mater Res A 2012, 100:1539-1549.
48. Gilbert M., Shaw W.J., Long J.R., Nelson K., Drobny G.P., Giachelli C.M., et al. Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. JBiol Chem 2000, 275:16213-16218.
49. Guo Y., Ma M., Sun R., Chen L., Song Y., Deng X.M. Biodegradable gelatin/beta-tricalcium phosphate composite microspheres as localized delivery of growth factor-velvet antler polypeptides by water-in-oil (W/O) emulsion process 2009, 1-4. 2009 ICBBE 2009 3rd International Conference on: IEEE, Bioinformatics and Biomedical Engineering.
50. Patterson J., Siew R., Herring S.W., Lin A.S., Guldberg R., Stayton P.S. Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials 2010, 31:6772-6781.
51. Zhao J., Ohba S., Shinkai M., Chung U.I., Nagamune T. Icariin induces osteogenic differentiation invitro in a BMP- and Runx2-dependent manner. Biochem Biophys Res Commun 2008, 369:444-448.
52. Cao H., Ke Y., Zhang Y., Zhang C.J., Qian W., Zhang G.L. Icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2. Int J Mol Med 2012, 29:435-439.
53. Weng L., Zhou Q.L., Ikejima T., Wang B.X. Anew polypeptide promoting epidermal cells and chondrocytes proliferation from Cervus elaphus Linnaeus. Acta Pharmacol Sin 2001, 36:913-916.
54. Urist M.R., Strates B.S. Bone morphogenetic protein. JDent Res 1971, 50:1392-1406.
55. Xiao-Hong D., Chang-Qin X., Jian-Hua H., Wen-Jiang Z., Bing S. Icariin delays homocysteine-induced endothelial cellular senescence involving activation of the PI3K/AKT-eNOS signaling pathway. Pharm Biol 2013, 51:433-440.
56. Petite H., Viateau V., Bensaid W., Meunier A., de Pollak C., Bourguignon M., et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000, 18:959-963.
57. Xie X.H., Wang X.L., Zhang G., He Y.X., Wang X.H., Liu Z., et al. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin. Biomed Mater 2010, 5:054109.
58. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
59. Ratanavaraporn J., Furuya H., Tabata Y. Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration. Biomaterials 2012, 33:304-316.
60. Kou P.M., Babensee J.E. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. JBiomed Mater Res A 2011, 96:239-260.
61. Kim S.E., Song S.H., Yun Y.P., Choi B.J., Kwon I.K., Bae M.S., et al. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32:366-373.
62. Wu G., Liu Y., Iizuka T., Hunziker E.B. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials 2010, 31:7485-7493.